Irritable Bowel Syndrome with Constipation
📧 Sign up to get email alerts when something new happens for Irritable Bowel Syndrome with Constipation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Electro-acupuncture for Irritable Bowel Syndrome With Constipation [NA]
A clinical trial update indicates electro-acupoint therapy is being studied for irritable bowel syndrome with constipation. The study is cur…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: "Efficacy and Safety of Linaclotide in Chronic Constipation" [Phase 4]
Phase 4 trial evaluating the efficacy and safety of linaclotide for chronic constipation is not yet recruiting. The study sponsor is Md Mehe…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Soluble and Osmotic Fibre (SOLOS) Diet for Constipation
The SOLOS Diet trial investigates soluble and osmotic fiber as a treatment for constipation. The study status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A Study of Virtual Reality and Linaclotide for IBS-C [NA]
A Mayo Clinic study is exploring whether virtual reality plus the drug linaclotide can help patients with irritable bowel syndrome with cons…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years [Phase 3]
A Phase 3 clinical trial is evaluating the safety and efficacy of tenapanor for irritable bowel syndrome with constipation in pediatric pati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C [Phase 3]
This clinical trial update outlines a Phase 3 safety study of tenapanor in pediatric patients aged 6 to under 18 with irritable bowel syndro…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: 4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs [Phase 2]
A Phase 2, multi-center 4-week dose-ranging trial evaluating tenapanor for irritable bowel syndrome with constipation in children aged 6 to …
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Single-center Exploratory Study of the Intestinal Microbiota in Patients Treated for Irritable Bowel Syndrome With Predominant Constipation and Methane Production
A single-center exploratory clinical trial assessing the intestinal microbiota in patients treated for irritable bowel syndrome with constip…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: The Beneficial Effects on the Intestinal Function of a Food Supplement Based on an Extract of Green Tea and a Pool of Probiotics in Subjects With Irritable Bowel Syndrome With Predominance of Constipation [NA]
A clinical trial is evaluating whether a food supplement made from green tea extract and a probiotic pool improves intestinal function in in…
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome With Constipation [NA]
A clinical trial is ongoing to evaluate fecal microbiota transplantation for relief of symptoms in irritable bowel syndrome with constipatio…
-
CLINICAL_TRIALS research · 2025-03-04Clinical Trial Update: Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation [NA]
A clinical trial update announcing recruitment for a study evaluating adding polyethylene glycol 3350 to a low FODMAP diet for irritable bow…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Efficacy of Chatbot for Irritable Bowel Syndrome (IBS) Patients [NA]
A clinical trial update shows ongoing enrollment for a study assessing the efficacy of a chatbot intervention in patients with various forms…
-
CLINICAL_TRIALS research · 2019-08-22Clinical Trial Update: An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation [Phase 4]
Open-label, long-term Phase 4 study assessing immunogenicity ofLinaclotide (LINZESS) in adults with irritable bowel syndrome with constipati…
-
CLINICAL_TRIALS research · 2014-04-14Clinical Trial Update: Mode of Action of Moviprep [Phase 4]
A Phase 4 clinical trial investigating the mode of action of Moviprep in functional constipation and IBS with constipation has completed.